Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

31 trials with published results (27%)

Research Maturity

77 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

7.0%

8 terminated out of 115 trials

Success Rate

90.6%

+4.1% vs benchmark

Late-Stage Pipeline

40%

46 trials in Phase 3/4

Results Transparency

40%

31 of 77 completed with results

Key Signals

31 with results91% success

Data Visualizations

Phase Distribution

90Total
Not Applicable (28)
Early P 1 (2)
P 1 (7)
P 2 (7)
P 3 (23)
P 4 (23)

Trial Status

Completed77
Unknown10
Recruiting9
Terminated8
Not Yet Recruiting6
Active Not Recruiting4

Trial Success Rate

90.6%

Benchmark: 86.5%

Based on 77 completed trials

Clinical Trials (115)

Showing 20 of 20 trials
NCT07554989Active Not RecruitingPrimary

Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms

NCT06201013Not ApplicableRecruitingPrimary

Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet

NCT07425015Not ApplicableRecruiting

Ambulatory Long Length URodynamics Evaluation

NCT05250908Not ApplicableActive Not Recruiting

INTIBIA Pivotal Study

NCT05715268Not ApplicableActive Not Recruiting

Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study

NCT03784170Not ApplicableCompletedPrimary

FemPulse Therapy for Overactive Bladder in Women

NCT07387315Phase 4Not Yet Recruiting

A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections

NCT07366918Not ApplicableRecruitingPrimary

Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder

NCT03681678Completed

Laser Therapy for Treatment of Urogenital Symptoms in Women

NCT01558856Not ApplicableCompletedPrimary

Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

NCT05880862Early Phase 1Active Not RecruitingPrimary

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

NCT07227285Phase 1Not Yet RecruitingPrimary

Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy

NCT05309993Not ApplicableTerminated

INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder

NCT07114640Phase 3Not Yet RecruitingPrimary

The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

NCT06197295Phase 4RecruitingPrimary

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

NCT06479720Phase 4Recruiting

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

NCT05968885Phase 4RecruitingPrimary

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

NCT06921915Not ApplicableCompletedPrimary

Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women

NCT06933407Recruiting

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

NCT06336304Recruiting

NXT Post-Market Clinical Follow-up

Scroll to load more

Research Network

Activity Timeline